Skip to content

Timely Reperfusion in Acute ST-segment Myocardial Infarction

Mobilizing Clinical Leadership to Achieve Timely Reperfusion in Acute ST-segment Elevation Myocardial Infarction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04614805
Enrollment
146
Registered
2020-11-04
Start date
2020-11-01
Completion date
2023-01-04
Last updated
2023-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction

Brief summary

The aim of the study is to monitor outcomes, especially time to reperfusion, in ST-elevation acute myocardial infarction patients.

Detailed description

In the regional health trust of North Norway, time to reperfusion in acute ST-elevation myocardial infarction is below the national average and below recommendations. The aim of this study is to monitor outcomes, especially time to reperfusion, in ST-elevation acute myocardial infarction patients. The study period is supposedly lasting for approximately 4 months, the time estimated to observe the clinical course of 100 patients. Before and during the study period, clinical leaders are encouraged to improve guideline adherence and to closely monitor the results of their own and collaborating institutions.

Interventions

BEHAVIORALMobilizing clinical leaders

Clinical leaders and clinical personnel will regularly receive feedback regarding performance of their own hospital as well as other providers in the regional health trust of North Norway.

Sponsors

University Hospital of North Norway
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patient diagnosed with acute myocardial infarction with ST-elevations within our regional health trust during Nov 1st and for approx 4 months, and with an indication for reperfusion therapy (thrombolysis and/pr PCI)

Exclusion criteria

* Reperfusion therapy not indicated or contraindicated

Design outcomes

Primary

MeasureTime frameDescription
Time to reperfusionThis parameter will be recorded within 1 week after patient inclusionInterval between 1st medical contact and opening of the infarction-related coronary artery.

Secondary

MeasureTime frameDescription
Ejection fraction at dischargeThis parameter will be recorded up to 6 months after patient inclusionSystolic function of the left ventricle
SurvivalThis parameter will be collected from patient's records during Nov -20 till Aug -21.Survival after 30 days from incident

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026